Evidence map›Paper›PMID 29734821›Full record

ArticleAmerican journal of Alzheimer's disease and other dementias2018

Cerebral Microbleeds in Advanced Dementia: Clinical and Pathological Correlates.

Inmaculada Boyano, Ana Ramos, Jorge López-Alvarez, Carolina Mendoza-Rebolledo, Emma Osa-Ruiz, Irene Rodríguez, Almudena Pérez, Eva Alfayate, Belén González, Laura Fernández and 3 more

Abstract read
In one paragraph

Article in American journal of Alzheimer's disease and other dementias, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Inmaculada Boyano1 Móstoles University Hospital, Madrid, Spain.ORCID 0000-0002-3641-8172
Ana Ramos2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Jorge López-Alvarez2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Carolina Mendoza-Rebolledo2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Emma Osa-Ruiz2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Irene Rodríguez2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Almudena Pérez2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Eva Alfayate2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Belén González2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Laura Fernández2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Luis Agüera-Ortiz2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Alberto Rábano2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Javier Olazarán2 Alzheimer's Center Reina Sofía Foundation-CIEN Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe conducted a longitudinal study to explore the clinical and pathological correlates of cerebral microbleeds (CMBs) in institutionalized patients with dementia.

methodsClinical and magnetic resonance imaging (MRI) data were extracted from 182 nursing home patients (mean age [standard deviation]: 81.3 [6.9], 78.0% female, and 83.4% moderate to severe dementia), which were divided according to the CMBs number and location. One-year follow-up data were obtained from 153 patients, and postmortem pathological diagnosis was available in 40 patients.

resultsCerebral microbleeds were observed in 42.9% of patients and were associated with MRI ischemic lesions ( P < .0005). In the adjusted analysis, lobar CMB predicted worsening of parkinsonism (standardized β: 0.43) and gait (standardized β: 0.24). A pathological diagnosis of Alzheimer's disease was less frequent in the brains of patients with lobar and deep CMB (33.3% vs 85.3%; P < .05).

conclusionCerebral microbleeds were linked to cerebrovascular disease and predicted motor deterioration in institutionalized people with advanced dementia.

Indexed as

Magnetic Resonance ImagingAged, 80 and overAlzheimer DiseaseBrainCerebral Amyloid AngiopathyCerebral HemorrhageDementiaFemaleHumansLongitudinal StudiesMaleSeverity of Illness IndexAlzheimer’s diseaseamyloid angiopathycerebral microbleedscerebrovascular diseasedementia

Identifiers

PMID29734821
PMCPMC10852440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.